302 related articles for article (PubMed ID: 17189468)
1. Effective bone engineering with periosteum-derived cells.
Agata H; Asahina I; Yamazaki Y; Uchida M; Shinohara Y; Honda MJ; Kagami H; Ueda M
J Dent Res; 2007 Jan; 86(1):79-83. PubMed ID: 17189468
[TBL] [Abstract][Full Text] [Related]
2. Periosteal progenitor cell fate in segmental cortical bone graft transplantations: implications for functional tissue engineering.
Zhang X; Xie C; Lin AS; Ito H; Awad H; Lieberman JR; Rubery PT; Schwarz EM; O'Keefe RJ; Guldberg RE
J Bone Miner Res; 2005 Dec; 20(12):2124-37. PubMed ID: 16294266
[TBL] [Abstract][Full Text] [Related]
3. Effects of allogenous periosteal-derived cells transfected with adenovirus-mediated BMP-2 on repairing defects of the mandible in rabbits.
Sun M; Tan W; Wang K; Dong Z; Peng H; Wei F
J Oral Maxillofac Surg; 2013 Oct; 71(10):1789-99. PubMed ID: 23676775
[TBL] [Abstract][Full Text] [Related]
4. Stimulatory effects of basic fibroblast growth factor and bone morphogenetic protein-2 on osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells.
Hanada K; Dennis JE; Caplan AI
J Bone Miner Res; 1997 Oct; 12(10):1606-14. PubMed ID: 9333121
[TBL] [Abstract][Full Text] [Related]
5. Bone formation following transplantation of genetically modified primary bone marrow stromal cells.
Sugiyama O; Orimo H; Suzuki S; Yamashita K; Ito H; Shimada T
J Orthop Res; 2003 Jul; 21(4):630-7. PubMed ID: 12798062
[TBL] [Abstract][Full Text] [Related]
6. Osteogenic response of bone marrow stromal cells from normal and ovariectomized rats treated with a low dose of basic fibroblast growth factor.
Varkey M; Kucharski C; Doschak MR; Winn SR; Brochmann EJ; Murray S; Matyas JR; Zernicke RF; Uludag H
Tissue Eng; 2007 Apr; 13(4):809-17. PubMed ID: 17394387
[TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic protein-2 decorated silk fibroin films induce osteogenic differentiation of human bone marrow stromal cells.
Karageorgiou V; Meinel L; Hofmann S; Malhotra A; Volloch V; Kaplan D
J Biomed Mater Res A; 2004 Dec; 71(3):528-37. PubMed ID: 15478212
[TBL] [Abstract][Full Text] [Related]
8. Superior mineralization and neovascularization capacity of adult human metaphyseal periosteum-derived cells for skeletal tissue engineering applications.
Chen D; Shen H; Shao J; Jiang Y; Lu J; He Y; Huang C
Int J Mol Med; 2011 May; 27(5):707-13. PubMed ID: 21369695
[TBL] [Abstract][Full Text] [Related]
9. Human osteoprogenitor bone formation using encapsulated bone morphogenetic protein 2 in porous polymer scaffolds.
Yang XB; Whitaker MJ; Sebald W; Clarke N; Howdle SM; Shakesheff KM; Oreffo RO
Tissue Eng; 2004; 10(7-8):1037-45. PubMed ID: 15363161
[TBL] [Abstract][Full Text] [Related]
10. Osteogenic Potential of Mouse Periosteum-Derived Cells Sorted for CD90 In Vitro and In Vivo.
Kim YK; Nakata H; Yamamoto M; Miyasaka M; Kasugai S; Kuroda S
Stem Cells Transl Med; 2016 Feb; 5(2):227-34. PubMed ID: 26718647
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of osteoblastic differentiation of mesenchymal stromal cells cultured by selective combination of bone morphogenetic protein-2 (BMP-2) and fibroblast growth factor-2 (FGF-2).
Maegawa N; Kawamura K; Hirose M; Yajima H; Takakura Y; Ohgushi H
J Tissue Eng Regen Med; 2007; 1(4):306-13. PubMed ID: 18038421
[TBL] [Abstract][Full Text] [Related]
12. Mixing conditions for cell scaffolds affect the bone formation induced by bone engineering with human bone marrow stromal cells, beta-tricalcium phosphate granules, and rhBMP-2.
Uchida M; Agata H; Sagara H; Shinohara Y; Kagami H; Asahina I
J Biomed Mater Res A; 2009 Oct; 91(1):84-91. PubMed ID: 18767063
[TBL] [Abstract][Full Text] [Related]
13. Osteogenic responses to different concentrations/ratios of BMP-2 and bFGF in bone formation.
Wang L; Huang Y; Pan K; Jiang X; Liu C
Ann Biomed Eng; 2010 Jan; 38(1):77-87. PubMed ID: 19921434
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow cells from normal and ovariectomized rats respond differently to basic fibroblast growth factor and bone morphogenetic protein 2 treatment in vitro.
Haque T; Uludag H; Zernicke RF; Winn SR; Sebald W
Tissue Eng; 2005; 11(3-4):634-44. PubMed ID: 15869440
[TBL] [Abstract][Full Text] [Related]
15. In vitro osteogenic response of rat bone marrow cells to bFGF and BMP-2 treatments.
Varkey M; Kucharski C; Haque T; Sebald W; Uludağ H
Clin Orthop Relat Res; 2006 Feb; 443():113-23. PubMed ID: 16462434
[TBL] [Abstract][Full Text] [Related]
16. Influence of platelet-rich plasma (PRP) on osteogenic differentiation of rat bone marrow stromal cells. An in vitro study.
Arpornmaeklong P; Kochel M; Depprich R; Kübler NR; Würzler KK
Int J Oral Maxillofac Surg; 2004 Jan; 33(1):60-70. PubMed ID: 14690661
[TBL] [Abstract][Full Text] [Related]
17. Osteogenic differentiation of human mesenchymal stem cells cultured with dexamethasone, vitamin D3, basic fibroblast growth factor, and bone morphogenetic protein-2.
Mostafa NZ; Fitzsimmons R; Major PW; Adesida A; Jomha N; Jiang H; Uludağ H
Connect Tissue Res; 2012; 53(2):117-31. PubMed ID: 21966879
[TBL] [Abstract][Full Text] [Related]
18. A comparative qualitative histological analysis of tissue-engineered bone using bone marrow mesenchymal stem cells, alveolar bone cells, and periosteal cells.
Zhu SJ; Choi BH; Huh JY; Jung JH; Kim BY; Lee SH
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Feb; 101(2):164-9. PubMed ID: 16448916
[TBL] [Abstract][Full Text] [Related]
19. Differential growth factor control of bone formation through osteoprogenitor differentiation.
Chaudhary LR; Hofmeister AM; Hruska KA
Bone; 2004 Mar; 34(3):402-11. PubMed ID: 15003788
[TBL] [Abstract][Full Text] [Related]
20. Transgene-activated mesenchymal cells for articular cartilage repair: a comparison of primary bone marrow-, perichondrium/periosteum- and fat-derived cells.
Park J; Gelse K; Frank S; von der Mark K; Aigner T; Schneider H
J Gene Med; 2006 Jan; 8(1):112-25. PubMed ID: 16142704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
